| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
|
Arch Intern Med
|
2008
|
4.66
|
|
2
|
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
|
JAMA
|
2013
|
4.33
|
|
3
|
Proof of principle: the predisposition, infection, response, organ failure sepsis staging system.
|
Crit Care Med
|
2011
|
2.30
|
|
4
|
Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
|
Arch Intern Med
|
2012
|
2.01
|
|
5
|
Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.
|
Ann Neurol
|
2009
|
1.73
|
|
6
|
The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis.
|
Crit Care
|
2010
|
1.72
|
|
7
|
Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study.
|
Crit Care
|
2013
|
1.66
|
|
8
|
Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial.
|
Chest
|
2010
|
1.63
|
|
9
|
Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
|
Neurology
|
2013
|
1.58
|
|
10
|
Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
|
J Am Coll Cardiol
|
2010
|
1.55
|
|
11
|
Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.
|
Eur Respir J
|
2013
|
1.51
|
|
12
|
The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
|
Crit Care Med
|
2014
|
1.49
|
|
13
|
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
|
Clin Chem Lab Med
|
2015
|
1.48
|
|
14
|
Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.
|
Crit Care
|
2013
|
1.19
|
|
15
|
Biomarkers of endothelial cell activation in early sepsis.
|
Shock
|
2013
|
1.18
|
|
16
|
Prognostic value of copeptin: one-year outcome in patients with acute stroke.
|
Stroke
|
2010
|
1.17
|
|
17
|
Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.
|
BMC Infect Dis
|
2011
|
1.15
|
|
18
|
Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia.
|
Am J Respir Crit Care Med
|
2007
|
1.15
|
|
19
|
Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage.
|
BMC Neurol
|
2010
|
1.11
|
|
20
|
It Is all about risk-adapted algorithms.
|
Crit Care Med
|
2013
|
1.08
|
|
21
|
The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery.
|
J Bone Joint Surg Am
|
2010
|
1.08
|
|
22
|
Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients.
|
PLoS One
|
2011
|
1.03
|
|
23
|
Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study.
|
J Am Geriatr Soc
|
2015
|
1.03
|
|
24
|
Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department.
|
BMC Pulm Med
|
2009
|
0.99
|
|
25
|
Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671].
|
BMC Fam Pract
|
2005
|
0.98
|
|
26
|
Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.
|
Chest
|
2012
|
0.96
|
|
27
|
Value of arterial blood gas analysis in patients with acute dyspnea: an observational study.
|
Crit Care
|
2011
|
0.95
|
|
28
|
Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
|
Clin Chem Lab Med
|
2015
|
0.91
|
|
29
|
Amyloid fibril polymorphism is under kinetic control.
|
J Am Chem Soc
|
2010
|
0.91
|
|
30
|
A combined cardiorenal assessment for the prediction of acute kidney injury in lower respiratory tract infections.
|
Am J Med
|
2012
|
0.90
|
|
31
|
Circulating biomarkers as surrogates for bloodstream infections.
|
Int J Antimicrob Agents
|
2007
|
0.89
|
|
32
|
Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis?
|
Endocrine
|
2011
|
0.89
|
|
33
|
Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives.
|
BMC Pulm Med
|
2010
|
0.88
|
|
34
|
Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study.
|
Swiss Med Wkly
|
2009
|
0.88
|
|
35
|
Dynamics and association of different acute stress markers with performance during a simulated resuscitation.
|
Resuscitation
|
2011
|
0.87
|
|
36
|
Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.
|
BMC Pulm Med
|
2012
|
0.87
|
|
37
|
The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review.
|
Clin Chem Lab Med
|
2015
|
0.85
|
|
38
|
Time-dependent Cox regression: serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection.
|
Int J Cardiol
|
2012
|
0.84
|
|
39
|
MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
|
Int J Cardiol
|
2010
|
0.84
|
|
40
|
Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.
|
COPD
|
2014
|
0.84
|
|
41
|
Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations.
|
Expert Rev Anti Infect Ther
|
2011
|
0.83
|
|
42
|
Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods - a prospective multinational trial.
|
Clin Chem Lab Med
|
2016
|
0.83
|
|
43
|
Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke.
|
PLoS One
|
2013
|
0.82
|
|
44
|
Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.
|
Trials
|
2013
|
0.81
|
|
45
|
Unraveling the Link between Malnutrition and Adverse Clinical Outcomes: Association of Acute and Chronic Malnutrition Measures with Blood Biomarkers from Different Pathophysiological States.
|
Ann Nutr Metab
|
2016
|
0.81
|
|
46
|
To escalate or to de-escalte--that is the question.
|
Crit Care Med
|
2011
|
0.81
|
|
47
|
Late-onset systemic sclerosis--a systematic survey of the EULAR scleroderma trials and research group database.
|
Rheumatology (Oxford)
|
2010
|
0.80
|
|
48
|
Copeptin as a stress marker prior and after a written examination--the CoEXAM study.
|
Stress
|
2015
|
0.79
|
|
49
|
[Procalcitonin - importance for the diagnosis of bacterial infections].
|
Ther Umsch
|
2008
|
0.78
|
|
50
|
Hyponatremia and anti-diuretic hormone in Legionnaires' disease.
|
BMC Infect Dis
|
2013
|
0.78
|
|
51
|
Growth hormone and outcome in patients with intracerebral hemorrhage: a pilot study.
|
Biomarkers
|
2011
|
0.78
|
|
52
|
Lymphocyte counts in patients with ANCA-associated vasculitis.
|
Rheumatol Int
|
2008
|
0.78
|
|
53
|
Reduction of phase artifacts in differential phase contrast computed tomography.
|
Opt Express
|
2011
|
0.78
|
|
54
|
Vitamin D Deficiency Strongly Predicts Adverse Medical Outcome Across Different Medical Inpatient Populations: Results From a Prospective Study.
|
Medicine (Baltimore)
|
2016
|
0.78
|
|
55
|
Biomarkers in the management of pneumonia.
|
Expert Rev Respir Med
|
2008
|
0.77
|
|
56
|
Physiological Achilles tendon length and its relation to tibia length.
|
Clin J Sport Med
|
2012
|
0.77
|
|
57
|
Interaction improves perception of gloss.
|
J Vis
|
2013
|
0.77
|
|
58
|
Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial.
|
PLoS One
|
2013
|
0.77
|
|
59
|
Can We Reduce Negative Blood Cultures With Clinical Scores and Blood Markers? Results From an Observational Cohort Study.
|
Medicine (Baltimore)
|
2015
|
0.77
|
|
60
|
Dexamethasone suppression test predicts later development of an impaired adrenal function after a 14-day course of prednisone in healthy volunteers.
|
Eur J Endocrinol
|
2010
|
0.76
|
|
61
|
Validation of a clinical prediction model for early admission to the intensive care unit of patients with pneumonia.
|
Acad Emerg Med
|
2012
|
0.76
|
|
62
|
Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation.
|
Ann Nutr Metab
|
2016
|
0.76
|
|
63
|
Meta-analysis of procalcitonin for sepsis detection.
|
Lancet Infect Dis
|
2007
|
0.76
|
|
64
|
Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort study.
|
Clin Chem Lab Med
|
2016
|
0.75
|
|
65
|
Corticosteroid treatment for community-acquired pneumonia--the STEP trial: study protocol for a randomized controlled trial.
|
Trials
|
2014
|
0.75
|
|
66
|
Prospective evaluation of biomarkers for prediction of quality of life in community-acquired pneumonia.
|
Clin Chem Lab Med
|
2016
|
0.75
|
|
67
|
Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies.
|
Expert Rev Respir Med
|
2013
|
0.75
|
|
68
|
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective.
|
Clin Chem Lab Med
|
2016
|
0.75
|
|
69
|
1440: VALIDATION OF THE ELECSYS BRAHMS PROCALCITONIN ASSAY IN PATIENTS WITH SEVERE SEPSIS OR SEPTIC SHOCK.
|
Crit Care Med
|
2016
|
0.75
|
|
70
|
DIAGNOSTIC ACCURACY OF BASAL CORTISOL LEVEL TO PREDICT ADRENAL INSUFFICIENCY IN COSYNTROPIN TESTING: RESULTS FROM AN OBSERVATIONAL COHORT STUDY WITH 804 PATIENTS.
|
Endocr Pract
|
2017
|
0.75
|
|
71
|
Peripheral monocytosis as a predictive factor for adverse outcome in the emergency department: Survey based on a register study.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
72
|
Head-to-head comparison of fee-for-service and diagnosis related groups in two tertiary referral hospitals in Switzerland: an observational study.
|
Swiss Med Wkly
|
2013
|
0.75
|
|
73
|
The role of procalcitonin in respiratory infections.
|
Curr Infect Dis Rep
|
2012
|
0.75
|
|
74
|
"Personalized" sepsis care with the help of specific biomarker levels on admission and during follow up: are we there yet?
|
Clin Chem Lab Med
|
2015
|
0.75
|